Clinical Trial Update: Safety Study of Filler Agent Composed of Autologous Mesenchymal Stem Cells and Hyaluronic Acid [Phase 1]

View source ↗

Summary

Phase 1 safety study evaluating a filler agent composed of autologous mesenchymal stem cells and hyaluronic acid for lipodystrophy and cosmetic procedures; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lipodystrophy

Drugs mentioned

• Filler Agent composed of autologous mesenchymal stem cells and hyaluronic acid (autologous mesenchymal stem cells with hyaluronic acid filler)

Snippet

Sponsor: Cryopraxis Criobiologia Ltda. | Conditions: Lipodystrophies, Aesthetics Procedure | Phase 1 | Status: UNKNOWN